Encapsulation of adenoviral vectors into chitosan-bile salt microparticles for mucosal vaccination

Journal of Biotechnology

Volumn 126, Issue 2, 2006, Pages 152-162

  Lameiro, Maria Helena ^a   Malpique, Rita ^b   Silva, Ana Carina ^b   Alves, Paula M ^a,b   Melo, Eurico ^a,c  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Adenoviral vectors; Bile salts; Chitosan; Microparticles; Mucosal immunization

Indexed keywords

ADENOVIRAL VECTORS; BILE SALTS; CHITOSANS; MICROPARTICLES; MUCOSAL IMMUNIZATION;

AMINES; ENCAPSULATION; NEGATIVE IONS; SOLUTIONS; SURFACE ACTIVE AGENTS; VIRUSES;

VACCINES;

ADENOVIRUS VECTOR; BILE SALT; CHITOSAN; DEOXYCHOLATE SODIUM; POLOXAMER; POLYSORBATE 80; SURFACTANT;

AQUEOUS SOLUTION; ARTICLE; DRUG FORMULATION; ENCAPSULATION; HUMAN; HUMAN CELL; INOCULATION; MICROENCAPSULATION; PH MEASUREMENT; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTIVITY;

ADENOVIRIDAE; BILE ACIDS AND SALTS; CACO-2 CELLS; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTESTINAL MUCOSA; MATERIALS TESTING; MICROSPHERES; TRANSFECTION; VIRAL VACCINES;

ADENOVIRIDAE;

EID: 33749524797     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2006.04.030     Document Type: Article

References (45)

1. Babiuk L.A., and Tikoo S.K. Adenoviruses as vectors for delivering vaccines to mucosal surfaces. J. Biotechnol. 83 (2000) 105-113
2. Beer S.J., Matthews C.B., Stein C.S., Ross B.D., Hilfinger J.M., and Davidson B.L. Poly(lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther. 5 (1998) 740-746
3. Bernkop-Schnürch A., Humenberger C., and Valenta C. Basic studies on bioadhesive delivery systems for peptide and protein drugs. Int. J. Pharm. 165 (1998) 217-225
4. Bieganski R.M., Fowler A., Morgan J.R., and Toner M. Stabilization of active recombinant retroviruses in an amorphous dry state with trehalose. Biotechnol. Prog. 14 (1998) 615-620
5. Bowersock T.L., Hogenesch H., Suckow M., Guimond P., Martin S., Borie D., Torregrosa S., Park H., and Park K. Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine 17 (1999) 1804-1811
6. Brayden D.J. Oral vaccination in man using antigens in particles: current status. Eur. J. Pharm. Sci. 14 (2001) 183-189
7. Cavanagh H.M., Dingwall D., Steel J., Benson J., and Burton M. Cell contact dependent extended release of adenovirus by microparticles in vitro. J. Virol. Methods 95 (2001) 57-64
8. Chen H. Recent advances in mucosal vaccine development. J. Control. Release 67 (2000) 117-128
9. Croyle M.A., Cheng X., and Wilson J.M. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther. 8 (2001) 1281-1290
10. Croyle M.A., Roessler B.J., Davidson B.L., Hilfinger J.M., and Amidon G.L. Factors that influence stability of recombinant adenoviral preparations for human gene therapy. Pharm. Dev. Technol. 3 (1998) 373-383
11. Darling A.J., Boose J.A., and Spaltro J. Virus assay methods: accuracy and validation. Biologicals 26 (1998) 105-110
12. Davidson B.L., Hilfinger J.M., and Beer S.J. Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors. Adv. Drug Deliv. Rev. 27 (1997) 59-66
13. Ferreira T.B., Alves P.M., Aunins J.G., and Carrondo M.J.T. Use of adenoviral vectors as veterinary vaccines. Gene Ther. 12 (2005) S73-S83
14. Garcia del Barrio G., Hendry J., Renedo M.J., Irache J.M., and Novo F.J. In vivo sustained release of adenoviral vectors from poly(d,l-lactic-co-glycolic) acid microparticles prepared by TROMS. J. Control. Release 94 (2004) 229-235
15. Graham F.L., and van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52 (1973) 456-467
16. Green M., and Pina M. Biochemical studies on adenovirus multiplication. IV. Isolation, purification, and chemical analysis of adenovirus. Virology 20 (1963) 199-207
17. Guang Liu W., and De Yao K. Chitosan and its derivatives-a promising non-viral vector for gene transfection. J. Control. Release 83 (2002) 1-11
18. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15 (1998) 1326-1331
19. Isaka M., Yasuda Y., Kozuka S., Taniguchi T., Matano K., Maeyama J., Komiya T., Ohkuma K., Goto N., and Tochikubo K. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant. Vaccine 18 (1999) 743-751
20. Jarry C., Leroux J.C., Haeck J., and Chaput C. Irradiating or autoclaving chitosan/polyol solutions: effect on thermogelling chitosan-beta-glycerophosphate systems. Chem. Pharm. Bull. (Tokyo) 50 (2002) 1335-1340
21. Kalyanasundaram S., Feinstein S., Nicholson J.P., Leong K.W., and Garver Jr. R.I. Coacervate microspheres as carriers of recombinant adenoviruses. Cancer Gene Ther. 6 (1999) 107-112
22. Kamen A., and Henry O. Development and optimization of an adenovirus production process. J. Gene Med. 6 Suppl. 1 (2004) S184-S192
23. Kawamata Y., Nagayama Y., Nakao K., Mizuguchi H., Hayakawa T., Sato T., and Ishii N. Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro. Biomaterials 23 (2002) 4573-4579
24. Lameiro M.H., Lopes A., Martins L.O., Alves P.M., and Melo E. Incorporation of a model protein into chitosan-bile salt microparticles. Int. J. Pharm. 312 (2006) 119-130
25. Lee K.Y., Jo W.H., Kwon I.C., Kim Y.-H., and Jeong S.Y. Physicochemical characteristics of self-aggregates of hydrophobically modified chitosans. Langmuir 14 (1998) 2329-2332
26. Lee K.Y., Jo W.H., Kwon I.C., Kim Y.-H., and Jeong S.Y. Structural determination and interior polarity of self-aggregates prepared from deoxycholic acid-modified chitosan in water. Macromolecules 31 (1998) 378-383
27. Lehr C.-M., Bouwstra J.A., Schacht E.H., and Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78 (1992) 43-48
28. Leslie S.B., Israeli E., Lighthart B., Crowe J.H., and Crowe L.M. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying. Appl. Environ. Microbiol. 61 (1995) 3592-3597
29. Maheshwari G., Jannat R., McCormick L., and Hsu D. Thermal inactivation of adenovirus type 5. J. Virol. Methods 118 (2004) 141-146
30. Mao H.Q., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., August J.T., and Leong K.W. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release 70 (2001) 399-421
31. Merkus F.W.H.M., Schipper N.G.M., Hermens W.A.J.J., Romeijn S.G., and Verhoef J.C. Absorption enhancers in nasal drug delivery: efficacy and safety. J. Control. Release 24 (1993) 201-208
32. Muzzarelli R.A. Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell. Mol. Life Sci. 53 (1997) 131-140
33. Nadeau I., and Kamen A. Production of adenovirus vector for gene therapy. Biotechnol. Adv. 20 (2002) 475-489
34. Nyberg-Hoffman C., and Aguilar-Cordova E. Instability of adenoviral vectors during transport and its implication for clinical studies. Nat. Med. 5 (1999) 955-957
35. O'Brien T., and Simari R.D. Gene therapy for atherosclerotic cardiovascular disease: a time for optimism and caution. Mayo Clin. Proc. 75 (2000) 831-834
36. Pandori M., Hobson D., and Sano T. Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. Virology 299 (2002) 204-212
37. Prego C., Garcia M., Torres D., and Alonso M.J. Transmucosal macromolecular drug delivery. J. Control. Release 101 (2005) 151-162
38. Qiang B., Segev A., Beliard I., Nili N., Strauss B.H., and Sefton M.V. Poly(methylidene malonate 2.1.2) nanoparticles: a biocompatible polymer that enhances peri-adventitial adenoviral gene delivery. J. Control. Release 98 (2004) 447-455
39. Ranaldi G., Marigliano I., Vespignani I., Perozzi G., and Sambuy Y. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1). J. Nutr. Biochem. 13 (2002) 157-167
40. Schauenstein K., Schauenstein E., and Wick G. Fluorescence properties of free and protein bound fluorescein dyes. I. Macrospectrofluorometric measurements. J. Histochem. Cytochem. 26 (1978) 277-283
41. Shu X.Z., and Zhu K.J. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int. J. Pharm. 233 (2002) 217-225
42. Sinha V.R., Singla A.K., Wadhawan S., Kaushik R., Kumria R., Bansal K., and Dhawan S. Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm. 274 (2004) 1-33
43. Thanou M., Verhoef J.C., and Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug. Deliv. Rev. 52 (2001) 117-126
44. van der Lubben I.M., Verhoef J.C., Borchard G., and Junginger H.E. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci. 14 (2001) 201-207
45. van der Lubben I.M., Verhoef J.C., van Aelst A.C., Borchard G., and Junginger H.E. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials 22 (2001) 687-694